Navigation Links
Generex Announces $3.0 Million Capital Investment
Date:1/25/2011

WORCESTER, Mass., Jan. 25, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (the "Company") (www.generex.com) (OTC Bulletin Board: GNBT) today announced that it entered into a securities purchase agreement with certain institutional investors on January 24, 2011.  The investors have agreed to purchase up to $6 million of shares of the Company's common stock and warrants to purchase shares of common stock.  At the initial closing, the investors will purchase an aggregate of 12,000,000 shares of common stock together with warrants to purchase an aggregate of 12,000,000 shares of common stock for a total purchase price of $3,000,000.  The investors will also have the option to purchase up to an additional $3,000,000 of shares of common stock and warrants to purchase shares of common stock during the 60 days following the initial closing.  The purchase price of any additional shares purchased by the investors, and the exercise price of any additional warrants issued to them, will be $0.25 per share.  

(Logo: http://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b)

The warrants issued by the Company to the investors will be immediately exercisable, expire five years after issuance, and have an exercise price of $0.25 per share.  The exercise price of the warrants issued to the investors will be subject to adjustment in the case of stock splits, stock dividends, combinations of shares, and similar recapitalization transactions.  The exercise price of the warrants will also be subject to an adjustment upon the occurrence of certain events, including the issuance by the Company of securities at a price per share less than the exercise price then in effect.  If the Company issues shares of common stock or options exercisable for or securities convertible into common stock at an effective price
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Generex Provides Additional Details for October 21st Live Video Webcast
2. Generex Common Stock to be Quoted on the OTCQB Under the Symbol GNBT Beginning Thursday, October 21, 2010
3. Generex Provides Additional Reverse Stock Split Information for the Consideration of Stockholders
4. Generex Scientific Advisor Weighs in on Reverse Stock Split Proposal
5. Generex Plans Rights Offering to Stockholders Following Reverse Stock Split
6. Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board
7. Generex Announces That Adjournment will be Sole Matter Considered at Special Meeting of Stockholders on September 17, 2010
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
9. Spherix Announces Closing of Registered Direct Offering of $2.77 Million in Common Stock and Warrants
10. Amgen Announces Webcast of 2010 Fourth Quarter and Full Year Financial Results
11. Sensus Healthcare Announces New Professional Skin Care Line - Sensus Skin Solutions™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015 US-Australian drug ... and its subsidiary, CanTx, Inc., and Yale University, on ... Cantrixil. The data was presented as an oral presentation ... Yale Medical School to the 62 nd Annual ... San Francisco, CA. ...
(Date:3/30/2015)... March 30, 2015    Intrexon Corporation ... biology, and Merck Serono, the biopharmaceutical business of ... today announced an exclusive strategic collaboration and license ... T-cell (CAR-T) cancer therapies. This collaboration advances Merck ... that modulate the immune system,s natural ability to ...
(Date:3/30/2015)... England , March 30, 2015 ... developing novel biological drugs to treat cancer, viral ... of Professor Sir John Bell , the ... Chairman of the Office for the Strategic Coordination ... with immediate effect.      (Photo: ...
(Date:3/30/2015)... MADISON, Wis. , March 30, 2015  FUJIFILM ... ("Fujifilm") and Cellular Dynamics International, Inc. (CEO: Robert ... leading developer and manufacturer of fully functioning human cells ... the two companies have entered into a definitive agreement ... offer to be followed by a second step merger. ...
Breaking Biology Technology:Yale University and Novogen Release Data on Cantrixil Mode of Action 2Yale University and Novogen Release Data on Cantrixil Mode of Action 3Yale University and Novogen Release Data on Cantrixil Mode of Action 4Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Immunocore Appoints Professor Sir John Bell to its Board of Directors 2Immunocore Appoints Professor Sir John Bell to its Board of Directors 3Immunocore Appoints Professor Sir John Bell to its Board of Directors 4Immunocore Appoints Professor Sir John Bell to its Board of Directors 5Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 2Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 4Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 5Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 6Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 7Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 8
... Medicine , Susan Huang and colleagues describe the use ... by integrating two freely available software packages, to identify ... data from patients admitted to a 750-bed academic medical ... authors found that the tool identified a number of ...
... ... a US report on Fermenters market. The US market for fermenters is projected to reach ... demand for biological drugs worldwide, and growing use of disposable or single-use fermenters. , ... San Jose, California (PRWEB) February 22, ...
... special ink infused with nanoparticles, Stanford engineer Yi Cui ... lightweight paper batteries and supercapacitors (which, like batteries, store ... well as stretchable, conductive textiles known as "eTextiles" ... of ordinary paper or fabric. While the technology ...
Cached Biology Technology:Tool identifies infection clusters; rate of T cell drop not helpful in decision to start treating HIV 2Tool identifies infection clusters; rate of T cell drop not helpful in decision to start treating HIV 3Tool identifies infection clusters; rate of T cell drop not helpful in decision to start treating HIV 4US Fermenters Market to Reach $180 million by 2015, According to New Report by Global Industry Analysts, Inc. 2US Fermenters Market to Reach $180 million by 2015, According to New Report by Global Industry Analysts, Inc. 3Nanotechnology sparks energy storage on paper and cloth 2Nanotechnology sparks energy storage on paper and cloth 3
(Date:3/26/2015)... 26, 2015 The Granite Club, ... and athletic club, today announced it has implemented a ... of movement for members and staff, while restricting access ... process, we selected FST,s IMID Access system because it ... our members and staff, in addition to unparalleled security," ...
(Date:3/24/2015)... 2015   NexID Biometrics LLC, whose spoof-mitigation ... today announced the beginning of shipments of version 2.0 ... The company, based in Potsdam, N.Y. ... Expo, which began here today at the Walter E. ... of its SDK boosts the accuracy rate range to ...
(Date:3/23/2015)...   HOYOS Labs , a leading global authentication ... the Company will demonstrate multiple biometrics-based technologies under its ... Connect:ID on March 23 through 25, 2015, in ... the IEEE Biometric Open Protocol Standard; free biometrics-based consumer ... control system. BOPS was invented by HOYOS Labs and ...
Breaking Biology News(10 mins):Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3
... National Institute of Standards and Technology (NIST) have developed ... governing a wide variety of cellular functions that may ... cells. The NIST technique measures changes in a ... that expresses the favorability of reactions in which molecules ...
... ANN ARBOR, Mich. We are all aware of the ... and how do we metabolize it? Research at the ... Biology Laboratory, and institutions in Canada and Sweden, has begun ... carbohydrates found in fruits and vegetables. Trillions of bacteria ...
... algae, rosemary and monk fruit could soon replace synthetic ... BHT and aspartame that label-conscious grocery shoppers are increasingly ... sweeteners and preservatives to naturally derived ones, and could ... & Engineering News , the weekly newsmagazine of the ...
Cached Biology News:New NIST method evaluates response to oxidation in live cells 2U-M scientists & colleagues investigate the fiber of our being 2
Mouse Aminopeptidase P2/XPNPEP2 Affinity Purified PAb Protein Family: Aminopeptidases, Metalloproteases...
... 53 new primer sets added in Dec ... than 3 hours , Detection from ... , Specific primers available for hundreds ... either real-time or end-point RT-PCR , ...
AGAROSE PREP, 50G, 1 EA. Category: Genephor Precast Gels....
in vitro Translation, Accessory Products...
Biology Products: